Sensus Healthcare, which sells low-energy x-ray systems for treating non-melanoma skin cancer and keloids, postponed its IPO on Wednesday. It had filed to raise $20 million by offering 1.8 million shares at a price range of $10 to $12.
Only eight IPOs have priced in 2016, all in the healthcare sector, thanks to significant support from insiders.
The Boca Raton, FL-based company was founded in 2010 and booked $10 million in sales for the 12 months ended December 31, 2015. It had planned to list on the Nasdaq under the symbol SRTS. Joseph Gunnar & Co. and Feltl and Company were set to be the joint bookrunners on the deal.
The article Sensing a difficult IPO market, Sensus Healthcare postpones $20 million IPO originally appeared on IPO investment manager Renaissance Capital's web site renaissancecapital.com.
Investment Disclosure: The information and opinions expressed herein were prepared by Renaissance Capital's research analysts and do not constitute an offer to buy or sell any security. Renaissance Capital, the Renaissance IPO ETF (symbol: IPO) or the Global IPO Fund (symbol: IPOSX) , may have investments in securities of companies mentioned.